Overview
Announcements

Ordinary Index Rebalancing in the North American Psychedelics Index | June 2021

In the ordinary rebalance the following composition will be implemented over a period starting on 17.06.2021 (cob) and ending on 18.06.2021 (cob) . The new composition and target weights will be fully reflected in the index open 21.06.2021:

JOHNSON & JOHNSON
ABBVIE INC
MYDECINE INNOVATIONS GROUP INC
ALGERNON PHARMACEUTICALS INC
CORE ONE LABS INC
SEELOS THERAPEUTICS INC
BETTERLIFE PHARMA INC
LOBE SCIENCES LTD
REVIVE THERAPEUTICS LTD
MIND MEDICINE MINDMED INC
RED LIGHT HOLLAND CORP
Compass Pathways PLC
FIELD TRIP HEALTH LTD
MIND CURE HEALTH INC
NUMINESS WELLNESS INC
HAVN LIFE SCIENCES INC
GREENBROOK TMS INC
PSYCHED WELLNESS LTD
ENTHEON BIOMEDICAL CORP
CYBIN INC
MINDSET PHARMA INC
NOVAMIND INC
OPTIMI HEALTH CORP